Sunday 18 October 2026
Export XAIR’s income statement to Excel — free account
Beyond Air, Inc.
XAIR Healthcare Medical Devices
Beyond Air, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $7.7 million, up 107.3% from fiscal 2025. In the quarter to June 2026, revenue was flat, EPS grew 64.1%, free cash flow fell 9.10% and total debt rose 127.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
2.16
0.05
−2.26%
Follow XAIR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 5 | 4 |
+8 more TTM periods Free account |
| (505.67%) | (323.58%) | (232.50%) | (173.14%) | ||
| (109.80%) | (101.61%) | (87.43%) | (87.40%) | ||
ROIC |
(174.89%) | (165.22%) | (146.26%) | (169.42%) | |
Return on Tangible Assets |
(140.38%) | (125.44%) | (106.62%) | (155.53%) | |
Average Days of Receivables |
54.13 | 51.62 | 60.68 | 56.12 | |
Free Cash Flow per Share |
(27.17) | (46.18) | (51.36) | (82.25) | |
Free Cash Flow |
(19.60) | (19.17) | (22.13) | (26.15) | |
Capital Expenditures |
(1.03) | (1.02) | (1.98) | (2.48) | |
| Other line items | |||||
Cash ROIC |
(48.45%) | (42.12%) | (46.00%) | (76.82%) | |
Accounts Receivable Turnover |
7.91 | 8.55 | 7.74 | 8.01 | |
Accounts Payable Turnover |
3.98 | 3.40 | 2.98 | 3.64 | |
Inventory Turnover |
3.95 | 3.89 | 3.28 | 2.60 | |
Average Days of Payables |
121.65 | 118.78 | 118.25 | 112.92 | |
Days of Inventory on Hand |
64.02 | 69.10 | 94.57 | 131.44 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
118.56% | 133.36% | 162.09% | 203.36% | |
Selling, General and Administrative Expense of Revenue |
250.37% | 248.14% | 259.24% | 365.65% | |
Share Based Compensation of Revenue |
61.68% | 68.78% | 72.40% | 103.24% | |
Interest Coverage |
(6.29) | (8.26) | (10.18) | (14.43) | |
Operating CF/Net income |
0.55 | 0.55 | 0.65 | 0.65 | |
Depreciation/Fixed assets |
0.55 | 0.48 | 0.46 | 0.41 | |
Capex/Depreciation |
(0.24) | (0.26) | (0.50) | (0.65) | |
Revenue per Share |
10.66 | 18.50 | 16.07 | 18.25 | |
Operating CF per Share |
(25.74) | (43.71) | (46.77) | (74.45) | |
Capex per Share |
(1.43) | (2.47) | (4.59) | (7.80) | |
Capex to Sales |
0.13 | 0.13 | 0.29 | 0.43 |
Columns are period end dates · fundamentals updated 28 Sep 2026